Related Articles
Patient with hormone receptor‑positive Her2‑negative metastatic breast cancer with visceral crisis with good response to abemaciclib and letrozole: A case report and review of the literature
Research progress on immunotherapy in triple‑negative breast cancer (Review)
CDK4/6 inhibitor resistance mechanisms and treatment strategies (Review)
Combination therapy with antibody‑drug conjugate RC48 (disitamab vedotin) and zimberelimab (PD‑1 inhibitor) successfully controlled recurrent HER2‑positive breast cancer resistant to trastuzumab emtansine: A case report
Precision medicine in breast cancer (Review)